Cytokinetics CYTK reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Cytokinetics beat estimated earnings by 77.45%, reporting an EPS of $-0.23 versus an estimate of $-1.02.
Revenue was up $86.12 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 1.68% drop in the share price the next day.
Here's a look at Cytokinetics's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.94 | -0.84 | -0.76 | -0.65 |
EPS Actual | -1.02 | -0.36 | -0.95 | -0.86 |
Revenue Estimate | 4.83M | 6.20M | 6.42M | 5.45M |
Revenue Actual | 1.15M | 55.60M | 5.44M | 2.84M |
To track all earnings releases for Cytokinetics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.